Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: The ALL90 study of the Japan Adult Leukemia Study Group

International Journal of Hematology

Volumn 68, Issue 3, 1998, Pages 279-289

  Ueda, T ^a   Miyawaki, S ^b   Asou, N ^c   Kuraishi, Y ^d   Hiraoka, A ^e   Kuriyama, K ^f   Minami, S ^g   Ohshima, T ^h   Ino, T ⁱ   Tamura, J ^j   Kanamaru, A ^k   Nishikawa, K ^l   Tanimoto, M ^m   Oh, H ⁿ   Saito, K ^o   Nagata, K ^p   Naoe, T ^m   Yamada, O ^q   Urasaki, Y ^a   Sakura, T ^b   Ohno, R ^r   more..

^a UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^b SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^c KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^d JIKEI UNIVERSITY HOSPITAL   (Japan)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^f NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^g JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^h SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

ⁱ FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^j GUNMA UNIVERSITY   (Japan)

^k HYOGO COLLEGE OF MEDICINE HOSPITAL   (Japan)

^l NARA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^m NAGOYA UNIVERSITY HOSPITAL   (Japan)

ⁿ CHIBA UNIVERSITY HOSPITAL   (Japan)

^o DOKKYO MEDICAL UNIVERSITY   (Japan)

^p ANJO KOSEI HOSPITAL   (Japan)

^q KAWASAKI MEDICAL SCHOOL   (Japan)

^r HAMAMATSU UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Acute lymphoblastic leukemia; Age; Japan Adult Leukemia Study Group (JALSG); Prognostic factor; Response oriented individualized chemotherapy

Indexed keywords

ACLARUBICIN; ASPARAGINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENOCITABINE; ETOPOSIDE; PREDNISOLONE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CROSS RESISTANCE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HUMAN; INDIVIDUALIZATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031723582     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00075-9     Document Type: Article

References (23)

1. Niemeyer CM, Hitchcock-Bryan S, Sallan SE Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. Semin Oncol. 12:1985;122-130.
2. Larson RA, Dodge RK, Burns PCet al. A five-drug remission induction regimen with intensive consolidation for adult with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood. 85:1995;2025-2037.
3. Hoelzer D, Thiel E, Buchner Tet al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 71:1988;123-131.
4. Ohno R, Kobayashi T, Tanimoto Met al. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between four or 12 courses in adult acute myeloid leukemia. Cancer. 71:1993;3888-3895.
5. Tanimoto, M., Suzuki, H., Miyawaki, S. et al. Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of Japan Adult Leukemia Study Group (JALSG). Int J Hematol 1998. In press.
6. Paciucci PA, Cuttner J, Holland JF Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia. Semin Oncol. 11:1984;36-40.
7. Bennett JM, Catovsky D, Daniel MTet al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 103:1985;626-629.
8. Ohno R, Tomonaga M, Ohshima Tet al. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Int J Hematol. 58:1993;73-81.
9. Kobayashi T, Miyawaki S, Tanimoto M.et al. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. J Clin Oncol. 14:1996;204-213.
10. Kaplan EL, Meier P Non-parametric estimation from incomplete observations. J Am Stat Assoc. 53:1985;457-481.
11. Fukushima T, Urasaki Y, Ueda Tet al. Treatment of acute lymphoblastic leukemia in adults: a review of 10 year study of Japan Adult Leukemia Study Group (In Japanese with English abstract). Rinsho Ketsueki. 38:1997;385-388.
12. Tobinai K, Kohno A, Shimada Yet al. Toxicity grading criteria of the Japan Clinical Oncology Group. Jpn J Clin Oncol. 23:1993;250-257.
13. Ohno R Current progress in the treatment of adult acute leukemia in Japan. Jpn J Clin Oncol. 22:1993;85-97.
14. Nagura E, Yamada K A controlled randomized clinical trial of adult acute leukemia (In Japanese with English abstract). Rinsyo Ketsueki. 26:1985;821-830.
15. Linker CA, Levitt LJ, O'Donnell M, Forman SJ, Ries CA Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood. 78:1991;2814-2822.
16. Hoelzer D, Thiel E, Ludwig WDet al. The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia. 6:1992;175-177.
17. Bassan R, Battista R, Rohatiner AZS et al. Treatment of adult acute lymphoblastic leukemia (ALL) over a 16 year period. Leukemia 1992;6 Suppl 2:186-190.
18. Keating MJ, Smith TL, Gehan EAet al. Factors related to length of complete remission in adult acute leukemia. Cancer. 45:1980;2017-2029.
19. Sebban C, Browmant GP, Lepage E, Fiere D Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemotherapy trials. Leukemia Res. 19:1995;861-868.
20. Copelan EA, McGuire EA The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 85:1995;1151-1168.
21. Robison LLet al. Assessment of the interrelationship of prognostic factors in childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 2:1980;5-13.
22. Oh H, Gale RP, Zhang M-J et al. Chemotherapy versus HLA-identical sibling transplants for adults with acute lymphoblastic leukemia in first remission. Bone Marrow Transpl 1998. In press.
23. 4-behenoyl-1-β-D-arabinofuranosylcytosine in patients with acute leukemia. Cancer Res. 43:1983;3412-3416.